Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Therapeutic Proteins: Strategic Market Analysis and Forecasts to' returned 218 results - Page 1 of 11   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the Market   GBI Research, Sep 2011, Pages: 142 59: Therapeutic Proteins Market, Global, Biogen Idec, SWOT Analysis, 2011 120 Figure 60: Therapeutic Proteins Market, Strategic Consolidations, M&A Deals by Year, 2011 121 Figure 61: Therapeutic Protein Ingredients - Global Strategic Business Report   Global Industry Analysts, Inc., Sep 2010, Pages: 553 Replace Fish Meal 20 Surplus Proteins Encroach the Functioning of Kidney 20 Substitute of Gelatin for Chocolate Mousse Market 20 Whey Proteins Become Trendy 20 4. GLOBAL MARKET OVERVIEW 21 Analysis G-Protein Coupled Receptors (GPCRs) - Global Strategic Business Report   Global Industry Analysts, Inc., Feb 2011, Pages: 299 Bioscience Pty Ltd (Australia) - Domain Therapeutics (France) - Euroscreen SA (Belgium) - Millipore Corporation (US) - Trevena, Inc. (USA) G-Protein Coupled Receptors (GPCRs) - Global Strategic Business Diabetic Nephropathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, April 2011, Pages: 72 Diabetic Nephropathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Diabetic Nephropathy Protein Drugs - Global Strategic Business Report   Global Industry Analysts, Inc., Aug 2010, Pages: 524 MARKET PERSPECTIVE Table 4: World Recent Past, Current & Future Analysis for Protein Drugs by Geographic Region - US and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million Therapeutic Apheresis - Global Strategic Business Report   Global Industry Analysts, Inc., Sep 2011, Pages: 126 . 57 9. MARKET PERSPECTIVE 58 Table 15: The US Recent Past, Current & Future Market Analysis for Therapeutic Apheresis by Procedure Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma   GBI Research, Feb 2010, Pages: 89 Pharmaceuticals 7.2.3 Silence Therapeutics plc 7.2.4 Cequent Pharmaceuticals, Inc 7.2.5 SantarisPharma A/S 8 RNA Therapeutics – R&D Pipeline Analysis 8.1 Strategic Pipeline Assessment 8.2 Profiles of Key Hemophilia Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Sep 2011, Pages: 135 Hemophilia Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Hemophilia Therapeutics - Pipeline Idiopathic Pulmonary Fibrosis (IPF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Dec 2011, Pages: 85 Idiopathic Pulmonary Fibrosis (IPF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Idiopathic Chronic Myelogenous Leukemia (CML) Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, June 2011, Pages: 91 Chronic Myelogenous Leukemia (CML) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Chronic Methicillin-Resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, March 2011, Pages: 89 Methicillin-Resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report Dermatophytic Onychomycosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, May 2011, Pages: 82 Dermatophytic Onychomycosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Dermatophytic Hypercholesterolemia Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, April 2011, Pages: 72 Hypercholesterolemia Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Hypercholesterolemia Diabetic Retinopathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, March 2011, Pages: 81 Diabetic Retinopathy Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Diabetic Retinopathy Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017   GlobalData, March 2011, Pages: 92 Diabetic Foot Ulcer (DFU) Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Summary GlobalData, the industry analysis specialist, has released its new report, “Diabetic Foot Ulcer Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Dec 2011, Pages: 117 Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Osteoporosis Therapeutics Muscular Dystrophy (MD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Nov 2011, Pages: 73 Muscular Dystrophy (MD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Muscular Dystrophy (MD Chemotherapy-Induced Neutropenia (CIN) Therapeutics -Pipeline Assessment and Market Forecasts to 2018   GlobalData, Nov 2011, Pages: 95 Chemotherapy-Induced Neutropenia (CIN) Therapeutics -Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Oct 2011, Pages: 131 Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Rheumatoid Arthritis Acute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Sep 2011, Pages: 89 Acute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Acute Ischemic Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network